logo
AAT Bioquest

Early activation antigen CD69 Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
2-[[26,27,28-Tris(carboxymethoxy)-2,8,14,20-tetrathiapentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3(28),4,6,9(27),10,12,15,17,19(26),21,23-dodecaen-25-yl]oxy]acetic acidIC500.65 [1], 0.71 [2], 12.59 [3], 15.0 [4]
4-Tert-Butylcalix[4]arene tetraacetic acidIC503.7 [1], 4.3 [2], 25.12 [3], 150.0 [4]
2-[[17,25,27-Tris(carboxymethoxy)-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3(28),4,6,9(27),10,12,15,17,19(26),21,23-dodecaenyl]oxy]acetic acidIC5014.0 [1], 21.0 [2], 50.12 [3], 1300.0 [4]
2-Acetamido-2-deoxy-beta-D-glucopyranoseIC50125892.54 [1], 316227.77 [2], 1000000.0 [3]
Duvoglustat hydrochlorideIC50630957.34 [1]
2-(Acetylamino)-2-deoxy-alpha-D-mannopyranoseIC501000000000.0 [1]
N-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-2-[[11,17,23-tris[[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]carbamothioylamino]-25,26,27,28-tetrapropoxy-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl]carbamothioylamino]oxan-3-yl]acetamideIC500.5 [1]
2-[[5,11,17,23-Tetratert-butyl-26,27,28-tris(carboxymethoxy)-2,8,14,20-tetrathiapentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaen-25-yl]oxy]acetic acidIC50398107.17 [1]
4-[[11,17,23-Tris[(4-carboxyphenyl)diazenyl]-25,26,27,28-tetrahydroxy-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl]diazenyl]benzoic acidIC5063.1 [1]
2-[[11,23,26,28-Tetratert-butyl-17,25,27-tris(carboxymethoxy)-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl]oxy]acetic acidIC50251188.64 [1]
2-[[5,11,17,23-Tetratert-butyl-27-(carboxymethoxy)-26,28-dihydroxy-2,8,14,20-tetraoxo-2lambda4,8lambda4,14lambda4,20lambda4-tetrathiapentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaen-25-yl]oxy]acetic acidIC5079432.82 [1]
2-[[27-(Carboxymethoxy)-26,28-dihydroxy-2,8,14,20-tetrathiapentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3(28),4,6,9(27),10,12,15,17,19(26),21,23-dodecaen-25-yl]oxy]acetic acidIC5079.43 [1]
2-[[26,27,28-Tris(carboxymethoxy)-25-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3(28),4,6,9(27),10,12,15,17,19(26),21,23-dodecaenyl]oxy]acetic acidIC5031622.78 [1]
[(2R,3R,4S,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-2-(triazol-1-yl)oxan-3-yl] acetateIC503981.07 [1]
N-[(2R,3S,4R,5R,6R)-2,4,5-Trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamideIC501000000000.0 [1]
N-[(2R,3S,4R,5R,6R)-2-[(2R,3R,4R,5S)-4,5-Dihydroxy-2-(hydroxymethyl)piperidin-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamideIC50501187.23 [1]
N-[(2R,3S,4R,5S,6R)-2-[(2R,3R,4R,5S)-4,5-Dihydroxy-2-(hydroxymethyl)piperidin-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamideIC5031622.78 [1]



References

This online tool may be cited as follows

MLA

"Quest Database™ Early activation antigen CD69 Inhibitors (IC50, Ki)." AAT Bioquest, Inc.20 Nov2024https://www.aatbio.com/data-sets/early-activation-antigen-cd69-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024November 20). Quest Database™ Early activation antigen CD69 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/early-activation-antigen-cd69-inhibitors-ic50-ki.
BibTeXEndNoteRefMan